Lapsed Apr 10, 2026 on the fee record · High confidence
20-year base term ends Jun 23, 2035
Second maintenance fee unpaid; grace period ended.
Held by Xlink Therapeutics, Inc.
Filed Jun 10, 2016 as application 15/179,701 · Granted Apr 10, 2018
Base term, 20 years from filing
Today
Lapsed Apr 10, 2026
2015
2035
Clock starts
Jun 23, 2015
Jun 23, 2015
No longer in force
Apr 10, 2026
Apr 10, 2026
Granted
Apr 10, 2018
Apr 10, 2018
Term would have run to
Jun 23, 2035
Jun 23, 2035
base term
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Jun 23, 2035: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 23, 2015, when application PCT/US2015/037071, the earliest non-provisional in its chain, was filed (this one was filed Jun 10, 2016) | Jun 23, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Apr 10, 2026 | High confidence |
| Computed term end | The steps above, in order | Apr 10, 2026 | High confidence |
This family
| Application PCT/US2015/037071 | PCT application no patent term | no patent term |
| US 9,403,858 | Lapsed on the fee record Aug 2024 | Aug 2024 |
| US 9,937,187 | this patent Apr 2026 | Apr 2026 |
| US 10,322,137 | In force Jun 2035 | Jun 2035 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 6, 2016 Reel 39089, frame 781 | Bilodeau, Mark T.; Moreau, Benoît; Brockman, Adam H. | Placon Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 18, 2017 Reel 43335, frame 608 | Meetze, Kristan; Whalen, Kerry; Wooster, Richard; Alargova, Rossitza G. | Placon Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 29, 2020 Reel 54215, frame 859 | Placon Therapeutics, Inc. | Xlink Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.